Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.

Authors

Thomas J Moore, George Washington University
Hanzhe Zhang
Gerard Anderson
G Caleb Alexander

Document Type

Journal Article

Publication Date

9-24-2018

Journal

JAMA Intern Med

DOI

10.1001/jamainternmed.2018.3931

Comments

epub ahead of print

APA Citation

Moore, T., Zhang, H., Anderson, G., & Alexander, G. (2018). Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.. JAMA Intern Med, (). http://dx.doi.org/10.1001/jamainternmed.2018.3931

Peer Reviewed

1